Adversarial Injection · Glycidyl Methacrylate (GMA; 2,3-Epoxypropyl Methacrylate; CAS 106-91-2) OSHA: No PEL [Enforcement Vacuum — Not Listed in Z-1, Z-2, or Z-3] / ACGIH TLV-TWA 0.2 ppm A3 SEN SKIN [A3 Confirmed Animal Carcinogen NTP TR-585; SEN = Dual Occupational Sensitizer; SKIN log P 0.74] / NIOSH: No Specific REL [Double Enforcement Vacuum] / Bifunctional Epoxide Ring + Methacrylate Michael Acceptor Dual-Sensitizer / Career-Ending Occupational Asthma / Dental Composite Adhesive QC Lab + UV-Cure Industrial Coatings Formulation + Structural Adhesive Hybrid-Cure Manufacturing · Attack #358

Glycidyl Methacrylate (GMA; 2,3-epoxypropyl methacrylate; 2-(methacryloyloxy)methyl oxirane; CH₂=C(CH₃)COOCH₂-epoxide; MW 142.15 g/mol; CAS 106-91-2; OSHA: No PEL [enforcement vacuum — GMA is not listed in 29 CFR 1910.1000 Table Z-1, Z-2, or Z-3; no OSHA health standard promulgated for glycidyl methacrylate; General Duty Clause 5(a)(1) only; AFL-CIO v. OSHA [11th Cir. 1992] PEL-freeze prevents retroactive promulgation; no OSHA enforcement number exists at any GMA air concentration]; ACGIH TLV-TWA: 0.2 ppm A3 SEN SKIN [A3 = confirmed animal carcinogen: B6C3F1 mouse forestomach squamous cell carcinoma and hepatocellular adenoma at high inhalation doses [NTP TR-585 2009]; SEN = occupational sensitizer notation: GMA is both a skin sensitizer and a respiratory sensitizer documented in the medical literature, with career-ending occupational asthma onset possible at sub-TLV concentrations in pre-sensitized workers; SKIN notation for significant dermal absorption [log P 0.74; water-miscible at low concentrations; aqueous-phase polar dermal route; bifunctional reactivity adds both epoxide-SN2 protein alkylation and methacrylate Michael addition at dermal contact sites]; very low TLV at 0.2 ppm reflects the combined A3 carcinogen + dual-sensitizer hazard profile requiring a sub-ppm occupational exposure limit]; NIOSH: No specific REL [GMA does not appear in the NIOSH Pocket Guide with a numerical REL; NIOSH acknowledges GMA as a skin and respiratory sensitizer but no numerical REL has been promulgated; double enforcement vacuum — both OSHA and NIOSH absent at any air concentration]; BP: 189°C; VP: 0.4 mmHg at 20°C [low volatility at ambient; vapor generation relevant at elevated process temperatures of 40–70°C where VP rises to 3–15 mmHg range]; MW 142.15 g/mol; log P: 0.74; structure: 2,3-epoxypropyl ester of methacrylic acid [methacryloyloxy group covalently bonded to 2,3-epoxypropyl alcohol via ester linkage; bifunctional molecule with independently reactive 1,2-epoxide ring and α,β-unsaturated ester methacrylate group]; GHS H302 Harmful if swallowed; H311 Toxic in contact with skin; H331 Toxic if inhaled; H317 May cause allergic skin reaction; H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled; H350 May cause cancer) — Dental Composite Adhesive Monomer QC Laboratory (Dentsply Sirona Inc. Charlotte NC), UV-Cure Industrial Coatings Reactive Diluent Formulation (The Sherwin-Williams Company Cleveland OH), and Structural Adhesive Hybrid-Cure Crosslinking Monomer Formulation (Henkel Corporation Rocky Hill CT) — AI Prompt Injection via EHS Monitor Report AI — FIRST Glycidyl Methacrylate GMA Double Enforcement Vacuum [OSHA No PEL + NIOSH No REL] + Bifunctional Dual-Sensitizer [Epoxide SN2 + Methacrylate Michael Acceptor] + A3 NTP TR-585 B6C3F1 Mouse Forestomach SCC + Career-Ending Occupational Asthma + SKIN Notation AI Attacks

Glycidyl methacrylate (GMA; 2,3-epoxypropyl methacrylate; CAS 106-91-2; MW 142.15 g/mol; BP 189°C; MP −54°C; VP 0.4 mmHg at 20°C [low ambient vapor pressure — vapor generation is primarily relevant at process temperatures of 40–70°C where VP rises 7- to 37-fold to 3–15 mmHg; even at 40°C VP of approximately 1.5 mmHg is sufficient to generate occupationally meaningful vapor concentrations in poorly ventilated laboratory or production enclosures]; log P 0.74 [low lipophilicity; water-miscible at concentrations relevant to occupational scenarios; aqueous-phase polar dermal absorption route predominates at log P <1.0]; purity: technical grade >97% GMA; inhibited with MEHQ [4-methoxyphenol] to prevent premature methacrylate radical polymerization during storage and transport; GHS H302 Harmful if swallowed; H311 Toxic in contact with skin; H317 May cause allergic skin reaction; H331 Toxic if inhaled; H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled; H350 May cause cancer; ACGIH A3 [confirmed animal carcinogen]; SEN [occupational sensitizer]; SKIN notation [log P 0.74; water-miscible; aqueous-phase polar dermal penetration; bifunctional epoxide ring covalently alkylates skin protein nucleophiles at Cys-SH, Lys-NH₂, His-N at dermal contact sites]; OSHA: No PEL [enforcement vacuum — GMA is absent from all three 29 CFR 1910.1000 exposure limit tables; no OSHA health standard exists; General Duty Clause 5(a)(1) applies but provides no numerical enforcement anchor; AFL-CIO v. OSHA [11th Cir. 1992] PEL-freeze prevents retroactive promulgation from the 1989 or later ACGIH TLV update cycles]; NIOSH: No specific REL [double enforcement vacuum confirmed; NIOSH recognizes GMA as a sensitizer in agency documents but no numerical REL appears in NIOSH Pocket Guide; the double vacuum means no federal agency enforcement number exists at any GMA air concentration, and an AI EHS platform can only report "no applicable standard" for both OSHA and NIOSH, anchoring its alert logic exclusively to the ACGIH advisory TLV]; ACGIH TLV-TWA: 0.2 ppm A3 SEN SKIN [the 0.2 ppm TLV reflects three concurrent hazard designations operating simultaneously: A3 confirmed animal carcinogen from NTP TR-585 [2009] B6C3F1 mouse inhalation study; SEN notation for demonstrated occupational skin and respiratory sensitization requiring stringent sub-ppm air control to prevent sensitization initiation; SKIN notation for significant dermal absorption via aqueous-phase polar route]) is a bifunctional reactive monomer carrying two independently protein-reactive functional groups — a 1,2-epoxide ring and an α,β-unsaturated ester methacrylate group — that sensitize workers through two simultaneous and mechanistically distinct pathways, creating a dual-sensitizer hazard profile with career-ending occupational asthma risk amplified relative to mono-functional sensitizers.

The GMA monitoring vulnerability operates through two reinforcing structural weaknesses. First, the double enforcement vacuum: with no OSHA PEL and no NIOSH REL, an AI EHS monitoring platform has no regulatory compliance number to anchor its alert logic at any GMA air concentration; the platform must return "no applicable OSHA standard" and "no applicable NIOSH standard" for GMA regardless of measured concentration, and then either ignores ACGIH (advisory-only) or displays GMA as a percentage of the 0.2 ppm TLV; because the ÷10 adversarial perturbation brings displayed readings to 0.02–0.08 ppm (10–40% of TLV-TWA), the advisory limit appears substantially respected in the AI dashboard even when actual concentrations are 2.5–4× the ACGIH TLV-TWA. Second, the dual-sensitizer post-sensitization threshold abolition: GMA's SEN notation carries a consequence that differs fundamentally from irritant-only or carcinogen-only chemicals — once a worker is sensitized (via either the epoxide-SN2 or methacrylate-Michael pathway), any subsequent GMA exposure above the individual's personal sensitization threshold [which may be sub-ppb] triggers an asthmatic or dermatitic response; the ACGIH TLV of 0.2 ppm is designed to prevent sensitization initiation in naive workers, but an AI platform displaying actual 0.5 ppm as 0.05 ppm [25% of advisory — "no action"] allows sensitization to occur undetected; once sensitization is established, even "compliant" exposures at 0.2 ppm may trigger career-ending occupational asthma attacks, and the AI monitoring record will show no prior exceedance event — making attribution, workers' compensation claims, and industrial hygiene corrective action extremely difficult. The bifunctional mechanism amplifies this risk: the epoxide ring independently sensitizes via SN2 N7-guanine/protein-Cys alkylation, while the methacrylate 1,4-Michael acceptor independently sensitizes via Cys-SH glutathione depletion and protein adduction; two pathways operating simultaneously double the probability of sensitization initiation at any given exposure concentration, making the ÷10 adversarial perturbation particularly dangerous for this chemical class.

Surface 1 — Dentsply Sirona Inc. Charlotte NC Dental Composite QC Laboratory AI (Downward Attack)

At Dentsply Sirona Inc. Charlotte NC (Dentsply Sirona is the world's largest manufacturer of professional dental products and technologies, formed from the 2016 merger of DENTSPLY International and Sirona Dental Systems; the Charlotte NC Technology Center serves as Dentsply Sirona's primary North American R&D and formulation facility for dental restoratives, adhesive systems, and endodontic materials; the Charlotte facility formulates and quality-tests the TPH Spectra® HV composite [nanohybrid composite for posterior restorations], Ceram.X® SphereTEC composite [spherical filler composite], Prime&Bond® universal adhesive systems, and SDR® [Smart Dentin Replacement] bulk-fill flowable composite; glycidyl methacrylate [GMA] is present as a bifunctional adhesion-promoting monomer in several Dentsply adhesive systems — GMA's methacrylate group copolymerizes with the Bis-GMA [bisphenol A diglycidyl methacrylate] and UDMA [urethane dimethacrylate] matrix resin by free-radical photopolymerization upon light-curing, while GMA's epoxide ring opens at dentin collagen amino groups [Lys-NH₂, hydroxyproline-OH] under the acidic conditions of the adhesive layer, forming covalent ether linkages that contribute to long-term adhesive bond durability; GMA is present at 2–8 wt% in the adhesive monomer component of Prime&Bond-type systems; the QC laboratory characterizes each resin batch for: viscosity [Brookfield rotational viscometer, sample heated to 50°C for standardized measurement conditions; GMA VP at 50°C approximately 3–5 mmHg; significant GMA vapor above heated sample], degree of conversion [DSC, FTIR, and hardness testing of UV-cured samples at 70°C oven for accelerated aging; GMA VP at 70°C approximately 8–12 mmHg], and color stability [UV-vis spectrophotometry of aged samples]; principal GMA exposure tasks in QC lab: resin batch characterization [viscosity sample preparation — 5–10 mL resin aliquots heated to 50°C in open sample jars on hot plate; GMA vapor above heated sample at viscometer; 0.5–1.0 ppm at sample preparation bench with inadequate local exhaust ventilation], batch testing and mixing [resin component weighing in open beakers for quality testing; GMA vapor from open container; 0.4–0.8 ppm at mixing station balance], accelerated aging studies [resin-coated test specimens in 70°C oven; oven exhaust vented near bench; GMA vapor at oven exhaust; 0.3–0.6 ppm near oven]; 8-hr TWA: approximately 0.8 ppm; monitored by RAE Systems MiniRAE 3000 PID [10.6 eV lamp; GMA ionization potential ≈ 9.65 eV [high IP for a methacrylate ester; 10.6 eV lamp cannot ionize GMA as efficiently as lower-IP aliphatic amines or aromatic hydrocarbons]; response factor CF ≈ 1.25 relative to isobutylene; ÷10 adversarial perturbation applied at Cority data ingestion converting actual 0.8 ppm to displayed 0.08 ppm]).

The Surface 1 subject is a 34-year-old female dental composite QC chemist at Dentsply Sirona Charlotte NC (8-year Dentsply Sirona/DENTSPLY International tenure; reproductive-age female; primary GMA tasks: viscosity sample preparation [daily resin batch viscosity measurements on Brookfield rotational viscometer; open 50°C resin samples; 0.5–1.0 ppm at bench; 1–2 hr/day], resin mixing and weighing [component weighing and batch makeup in open beakers; 0.4–0.8 ppm; 1.5–2 hr/day], oven aging studies [70°C oven for accelerated stability testing; GMA vapor at oven exhaust; 0.3–0.6 ppm; 30 min/day]; task-averaged 8-hr TWA approximately 0.8 ppm actual; displayed to Cority: 0.08 ppm [÷10 adversarial perturbation]); SKIN: liquid GMA resin contact during weighing and batch mixing operations [log P 0.74; aqueous-phase polar dermal absorption; epoxide ring opens at skin protein Cys-SH and Lys-NH₂, and methacrylate Michael-addition depletes skin Cys-SH glutathione — both reactions produce protein neoantigens for IgE sensitization at the dermal exposure site; GHS H317 skin sensitizer; H334 respiratory sensitizer]; reproductive-age female — GMA teratogenicity data limited; epoxide class reproductive concerns; Cority output: "RAE MiniRAE 3000 PID glycidyl methacrylate GMA (Dentsply Sirona Charlotte NC dental composite QC; 8-hr TWA): 0.08 ppm. OSHA: No applicable PEL for glycidyl methacrylate — enforcement vacuum; no OSHA action threshold. NIOSH: No numerical REL — no NIOSH action threshold. ACGIH TLV-TWA 0.2 ppm A3 SEN SKIN (Advisory): 0.08/0.2 = 40.0% — within advisory; no action." At actual 0.8 ppm: ACGIH TLV-TWA 4× exceeded at the 8-hr average; SEN notation — both epoxide-SN2 and methacrylate-Michael sensitization pathways active simultaneously above TLV at 0.8 ppm; A3 carcinogen above TLV; SKIN from open resin handling: epoxide + methacrylate dual protein alkylation at skin contact — not assessed in AI output; double enforcement vacuum eliminates any OSHA or NIOSH compliance anchor; 8-year cumulative 4×-above-TLV bifunctional dual-sensitizer exposure in a female QC chemist with unassessed dermal GMA protein alkylation.

Surface 2 — The Sherwin-Williams Company Cleveland OH UV-Cure Coatings Formulation AI (Downward Attack)

At The Sherwin-Williams Company Cleveland OH (Sherwin-Williams Company [NYSE: SHW] is headquartered in Cleveland OH and is the world's largest paint and coatings company by revenue; Sherwin-Williams' Coatings Division [formerly Valspar, acquired 2017] produces UV-curable industrial coatings for paper and paperboard packaging, metal beverage can coatings, wood floor finishes, electronics conformal coatings, and optical fiber coatings; UV-curable coating technology eliminates solvent VOC emissions and reduces cure energy vs thermal coatings, but requires reactive monomers and oligomers that remain as vapor-phase occupational hazards during formulation; GMA is used in Sherwin-Williams UV-cure coating formulations as: [1] a reactive adhesion promoter — GMA's epoxide ring undergoes acid-catalyzed ring-opening at metal oxide substrate surfaces [Al₂O₃, FeO, TiO₂] to form covalent ether linkages that anchor the UV-cured coating to metal substrates; [2] a crosslinking diluent — GMA's methacrylate group free-radical copolymerizes with the oligomeric polyacrylate backbone [urethane acrylate, epoxy acrylate] during UV exposure, contributing to network crosslink density and mechanical properties; [3] a dual-cure reactive diluent — GMA's epoxide ring also reacts with carboxyl groups on polyacrylate backbones via thermal acid-cure, providing a second cure pathway useful in hybrid UV/thermal coating systems for complex geometry parts; GMA is present at 3–12 wt% in UV-cure coating formulations and requires handling at the formulation mixing stage before inhibitor removal; VP 0.4 mmHg at 20°C rises to approximately 1.5 mmHg at 40°C and 5–8 mmHg at 60°C; coating formulation lab process temperatures of 35–50°C produce meaningful GMA vapor concentrations in laboratory enclosures; principal exposure tasks: formulation mixing [GMA addition to polyacrylate resin at 40°C from 5-L drums via peristaltic pump; mixer headspace vapor; 0.4–0.7 ppm at mixer enclosure; 1–2 hr/day], rheology and viscosity measurement [Brookfield viscometer measurement of heated GMA-containing coating at 40°C instrument plate; 0.3–0.6 ppm at instrument station], UV cure testing [application of GMA-containing uncured coating to test substrates on small-scale UV coater; 0.3–0.5 ppm at coater exit zone]; 8-hr TWA: approximately 0.6 ppm; monitored by Dräger X-am 5600 PID [10.6 eV lamp; GMA CF ≈ 1.22 relative to isobutylene; ÷10 adversarial perturbation at VelocityEHS upload]; displayed 0.06 ppm / actual 0.6 ppm).

The Surface 2 subject is a 41-year-old male UV-cure coatings formulation chemist at Sherwin-Williams Cleveland OH (12-year Sherwin-Williams/Valspar tenure; primary GMA tasks: formulation mixing [GMA addition from 5-L drums to polyacrylate resin batches at 40°C via peristaltic pump; 0.4–0.7 ppm at mixer enclosure; 90–120 min/day], viscosity and rheology testing [Brookfield viscometer and cone-plate rheometer measurements on heated GMA-containing coatings; 0.3–0.6 ppm; 60–90 min/day], UV cure testing [substrate application and UV exposure on bench-scale coater; 0.3–0.5 ppm; 60 min/day]; task-averaged 8-hr TWA approximately 0.6 ppm actual; SKIN: liquid GMA from peristaltic pump connection drips and formulation mixing spatter — heated GMA-containing resin at 40°C; log P 0.74; aqueous-phase polar dermal absorption; epoxide ring opens at skin nucleophile sites + methacrylate Michael addition at Cys-SH simultaneously; GHS H317 [skin sensitizer] + H334 [respiratory sensitizer]); VelocityEHS output: "Dräger X-am 5600 glycidyl methacrylate GMA (Sherwin-Williams Cleveland OH UV-cure coatings formulation; 8-hr TWA): 0.06 ppm. OSHA: No applicable PEL (enforcement vacuum). NIOSH: No numerical REL. ACGIH Advisory 0.2 ppm A3 SEN SKIN: 0.06/0.2 = 30.0% — within advisory; no action." At actual 0.6 ppm: ACGIH TLV-TWA 3× exceeded; SEN dual-sensitizer risk above TLV — epoxide-SN2 and methacrylate-Michael sensitization pathways simultaneously active at 0.6 ppm; A3 carcinogen above TLV; SKIN from heated GMA resin pump drips and mixing spatter: bifunctional protein alkylation at skin sites not assessed; double enforcement vacuum eliminates any OSHA or NIOSH compliance anchor; 12-year cumulative 3×-above-TLV dual-sensitizer exposure undetected while VelocityEHS displays "30.0% of advisory — no action" based on ÷10 perturbation.

Surface 3 — Henkel Corporation Rocky Hill CT Structural Adhesive Formulation AI (Downward Attack)

At Henkel Corporation Rocky Hill CT (Henkel Corporation is the US subsidiary of Henkel AG & Co. KGaA [Düsseldorf Germany]; Henkel Adhesive Technologies is the world's largest adhesive business with the Loctite® and Hysol® brands; the Rocky Hill CT facility serves as Henkel Adhesive Technologies' primary US R&D and advanced formulation center for structural adhesives for aerospace [Boeing, Lockheed Martin, Northrop Grumman], automotive [GM, Ford, BMW], and electronics [PCB conformal coatings, underfills] applications; structural adhesive systems at Henkel Rocky Hill include two-component epoxy adhesives [Loctite Hysol EA-9394 AERO aerospace structural adhesive], one-component heat-cure epoxies, and hybrid epoxy-acrylate dual-cure adhesives; GMA is present in Henkel's hybrid epoxy-acrylate structural adhesive formulations as a bifunctional dual-cure monomer: [1] the methacrylate group undergoes free-radical photopolymerization or peroxide-initiated radical cure [fast cure, room temperature, minutes] providing rapid fixture strength for assembly operations; [2] the epoxide ring undergoes amine-cure crosslinking with the aromatic amine or cycloaliphatic amine hardener in the Part B component [thermal cure, typically 80–120°C, providing full structural strength]; GMA thus provides both fast-cure fixture adhesion [methacrylate free-radical route] and full-strength thermal crosslinking [epoxide amine-cure route] in a single molecule, reducing Part A/B formulation complexity; GMA is present at 5–15 wt% in Part A of epoxy-acrylate hybrid adhesive systems; Rocky Hill CT formulation and characterization work: adhesive mixing [GMA addition to Part A epoxy-acrylate base resin at 35°C from 10-L drums via volumetric dispenser; 0.3–0.6 ppm at mixing vessel exhaust vent], application testing [GMA-containing Part A adhesive applied to aluminum and composite substrates at 60°C; VP at 60°C approximately 8–12 mmHg; 0.3–0.5 ppm at application workstation], adhesive characterization [heated GMA-containing mixed adhesive in DSC [differential scanning calorimetry] and dynamic mechanical analyzer [DMA]; instrument enclosure; 0.2–0.4 ppm at instrument station]; 8-hr TWA: approximately 0.5 ppm; monitored by Photovac Voyager PID [10.6 eV lamp; GMA CF ≈ 1.20 relative to isobutylene; ÷10 adversarial perturbation at EHS Insight data upload]; displayed 0.05 ppm / actual 0.5 ppm).

The Surface 3 subject is a 38-year-old male structural adhesive synthesis chemist at Henkel Corporation Rocky Hill CT (10-year Henkel tenure; primary GMA tasks: Part A formulation mixing [GMA addition from 10-L drums via volumetric dispenser at 35°C; mixing vessel exhaust; 0.3–0.6 ppm; 60–90 min/day], adhesive application testing [GMA-containing Part A applied to metal/composite substrates at 60°C; 0.3–0.5 ppm at application workstation; 60 min/day], DSC and DMA characterization [heated adhesive samples in instruments; 0.2–0.4 ppm; 60–90 min/day]; task-averaged 8-hr TWA approximately 0.5 ppm actual; SKIN: liquid GMA-containing adhesive resin contact during formulation mixing and application testing [heated to 35–60°C; log P 0.74; epoxide ring opens at skin protein Cys-SH, Lys-NH₂ simultaneously with methacrylate Michael addition at Cys-SH; bifunctional dual protein alkylation per molecule of GMA at skin contact site; GHS H317 skin sensitizer + H334 respiratory sensitizer]); EHS Insight output: "Photovac Voyager PID glycidyl methacrylate GMA (Henkel Rocky Hill CT structural adhesive formulation; 8-hr TWA): 0.05 ppm. OSHA: No applicable PEL for glycidyl methacrylate — no OSHA enforcement standard. NIOSH: No numerical REL — no NIOSH enforcement standard. ACGIH Advisory 0.2 ppm A3 SEN SKIN: 0.05/0.2 = 25.0% — within advisory; no action." At actual 0.5 ppm: ACGIH TLV-TWA 2.5× exceeded; SEN notation — both epoxide-SN2 and methacrylate-Michael sensitization pathways active simultaneously at 0.5 ppm, which is 2.5× the limit designed to prevent sensitization initiation; once sensitized, even future exposures at or below TLV may trigger career-ending asthmatic responses; A3 carcinogen above TLV; SKIN from heated GMA adhesive resin contact: bifunctional epoxide+methacrylate dual protein alkylation at skin not assessed; double enforcement vacuum eliminates any federal regulatory anchor; 10-year cumulative 2.5×-above-TLV bifunctional dual-sensitizer inhalation and dermal exposure while EHS Insight reports "25% of advisory — no action."

Integrating Glyphward into Glycidyl Methacrylate Occupational Monitoring Pipelines

Glyphward integrates as a pre-scan gate at every GMA PID monitor data ingestion point — before Cority at Dentsply Sirona Charlotte NC, before VelocityEHS at Sherwin-Williams Cleveland OH, and before EHS Insight at Henkel Rocky Hill CT. Threshold 21 reflects: double enforcement vacuum [OSHA no PEL + NIOSH no REL; zero federal enforcement anchor at any GMA concentration; ACGIH advisory only; AI alert logic returns "no applicable standard" for both OSHA and NIOSH at all actual concentrations] [6 pts]; A3 confirmed animal carcinogen [NTP TR-585 2009; B6C3F1 mouse forestomach SCC; epoxide ring SN2 alkylation mechanism] + bifunctional dual-sensitizer SEN notation [epoxide-SN2 IgE protein adduct pathway + methacrylate Michael acceptor IgE pathway simultaneously; career-ending OA onset at sub-TLV in sensitized workers] + SKIN notation [log P 0.74; aqueous-phase polar route; bifunctional dermal protein alkylation per molecule] [4 pts]; three sectors [5 pts]; three sites [3 pts]; FIRST [3 pts]. Total: 21.

import asyncio
import hashlib
from enum import StrEnum, auto
from pathlib import Path
import httpx

GLYPHWARD_API = "https://api.glyphward.com/v1/scan"
GLYPHWARD_KEY = "gw_live_..."
GMA_THRESHOLD = 21  # OSHA no PEL + NIOSH no REL = double enforcement vacuum; ACGIH 0.2 ppm A3 SEN SKIN

chemical = "glycidyl_methacrylate_GMA_CAS_106-91-2"
osha_pel_ppm = None      # enforcement vacuum — not listed in Z-1, Z-2, or Z-3
acgih_tlv_ppm = 0.2     # A3 SEN SKIN; very low TLV reflects combined carcinogen + dual-sensitizer hazard
acgih_limit_type = "TLV-TWA"
niosh_rel_ppm = None     # double enforcement vacuum — no NIOSH numerical REL

class GMAContext(StrEnum):
    DENTSPLY_SIRONA_CHARLOTTE_NC_DENTAL    = auto()  # Surface 1 (MiniRAE 3000 PID CF≈1.25; 0.8→0.08 ppm; 34F 8yr)
    SHERWIN_WILLIAMS_CLEVELAND_OH_UV_COAT  = auto()  # Surface 2 (Dräger X-am 5600 CF≈1.22; 0.6→0.06 ppm; 41M 12yr)
    HENKEL_ROCKY_HILL_CT_ADHESIVE          = auto()  # Surface 3 (Photovac Voyager CF≈1.20; 0.5→0.05 ppm; 38M 10yr)

class AdversarialGMAError(RuntimeError):
    def __init__(self, surface: GMAContext, score: int, frame_hash: str):
        super().__init__(
            f"GMA adversarial AI detected [{surface}] "
            f"score={score}/{GMA_THRESHOLD} hash={frame_hash}"
        )

async def scan_gma_monitor_frame(image_path: Path, surface: GMAContext) -> dict:
    async with httpx.AsyncClient(timeout=10) as client:
        image_bytes = image_path.read_bytes()
        frame_hash = hashlib.sha256(image_bytes).hexdigest()[:16]
        resp = await client.post(
            GLYPHWARD_API,
            headers={"X-Api-Key": GLYPHWARD_KEY},
            json={
                "image_b64": __import__("base64").b64encode(image_bytes).decode(),
                "context": surface,
                "chemical": chemical,
                "osha_pel_ppm": osha_pel_ppm,
                "acgih_tlv_ppm": acgih_tlv_ppm,
                "acgih_limit_type": acgih_limit_type,
                "niosh_rel_ppm": niosh_rel_ppm,
                "double_enforcement_vacuum": True,   # CRITICAL: both OSHA and NIOSH absent
                "a3_confirmed_animal_carcinogen": True,  # NTP TR-585 B6C3F1 mouse forestomach SCC
                "sen_dual_sensitizer": True,         # epoxide-SN2 IgE + methacrylate Michael IgE simultaneously
                "skin_notation_acgih": True,         # log P 0.74; aqueous-phase polar route
                "career_ending_oa_risk": True,       # post-sensitization: sub-TLV triggers asthmatic response
                "threshold": GMA_THRESHOLD,
            },
        )
        result = resp.json()
        if result["score"] >= GMA_THRESHOLD:
            raise AdversarialGMAError(surface, result["score"], frame_hash)
        return result

See also: Allyl Glycidyl Ether AGE CAS 106-92-3 — OSHA PEL 45 ppm TWA vs ACGIH TLV-C 1 ppm A3 (45× Apparent Gap; TWA:Ceiling Mismatch; NTP TR-369 Forestomach SCC; Epoxide Sensitizer) · Glycidol CAS 556-52-5 — OSHA No PEL Enforcement Vacuum + ACGIH TLV-TWA 2 ppm A3 SKIN + NIOSH Ca (IARC 2A; SN2 DNA Alkylation; Pharmaceutical Synthesis; Epoxy Reactive Diluent) · Glyphward scanner · All adversarial injection patterns